J&J Pumps $245M into the Advancement of Cutting-Edge CAR-T Therapies
Global pharmaceutical giant Johnson & Johnson has made a significant $245M investment to boost the development of next-generation CAR-T...
top of page
.jpg)
New drug Express
Drug r&d newsletter | pharmaceutical insight
Search
bottom of page